U.S. cosmetics regulation changed materially in 2022 with the passage of the Modernization of Cosmetics Regulation Act (MoCRA), the most significant update to FDA cosmetics authority in 80 years. Anyone sourcing private-label cosmetics in the U.S. is now sourcing inside a frame that didn't exist three years ago, and most factory marketing materials haven't caught up.

MoCRA registration. Every facility manufacturing or processing cosmetic products for the U.S. market is required to register with the FDA — and every cosmetic product on the market is required to be listed by responsible person. The FDA's MoCRA overview is the canonical reference. Registration is now part of how you verify a U.S. manufacturer is legitimate.

Adverse event reporting. Brands and manufacturers are required to maintain records and report serious adverse events to the FDA. Your private-label agreement should specify who maintains the records and who files reports.

Substantiation. MoCRA requires safety substantiation for every cosmetic product. The substantiation file lives with the responsible person — usually the brand. Factories will often help build the file, but the regulatory liability is yours.

GMP under MoCRA. The FDA is in the process of issuing formal cosmetic GMP regulations under MoCRA. Until those regulations are final, the de facto GMP standard for U.S. cosmetics manufacturing is ISO 22716 — the international cosmetics GMP standard. Strong U.S. cosmetics labs are ISO 22716 certified by a recognized third party. Weaker ones claim "GMP-compliant" without third-party audit.

FDA cosmetic guidance. The FDA's Cosmetics GMP Guidelines remain a useful starting point even pre-MoCRA-final-rule.

The practical implication: if you're vetting a U.S. cosmetics manufacturer in 2026 and they can't produce a current MoCRA registration number and a current ISO 22716 certificate, the conversation is over.

The U.S. cosmetics manufacturing industry is geographically concentrated — four states host the bulk of credible private-label and contract-manufacturing capacity.

Southern California (Los Angeles, Orange County, San Diego). The largest cluster, anchored by skincare and color cosmetics. Strong on prestige skincare emulsions, sun care, complex serums, and cosmetic actives sourcing. Many of the labs supply both indie brands and prestige chain retail. MOQs lean lower (some labs accept 250-500 units) because the cluster competes hard on accessibility for emerging brands.

New Jersey / New York metro. Heritage hub for fragrance, lipstick, mascara, and color cosmetics. Strong on filling and packaging operations close to the prestige beauty industry's commercial center. MOQs usually higher (1,000-5,000) but with deeper packaging and tooling integration.

Florida (Miami, Orlando, Tampa). Growing cluster for skincare, hair care, and Latin American export-oriented brands. Often well-priced, with regulatory expertise on bilingual labels and international markets.

Utah (Salt Lake City corridor). Originally a supplement hub that has expanded into skincare, often with strong GMP audit posture inherited from the supplement industry's stricter compliance culture. Strong on clean-beauty positioning and certification stacks.

Smaller but real pockets exist in Texas (Austin, Dallas), Pennsylvania, and the Pacific Northwest. The cluster matters because freight, supplier networks, and packaging vendor relationships compound geographically — a cosmetics lab in a cluster has access to packaging suppliers a lab in isolation doesn't.

Five sources, in roughly the order they're worth running.

1. The FDA's MoCRA registration database. Live and searchable. Every U.S. cosmetics facility producing for commercial sale is required to be listed. Cross-reference candidate factories against the registry — if they're not there, they're either operating illegally or not actually U.S.-domiciled.

2. ISO 22716 certified facility lists. The major certifying bodies (NSF International, SGS, Bureau Veritas, Intertek, TÜV) publish lists of facilities they've certified to ISO 22716. These are tighter pools than the MoCRA registry because they involve real third-party audit. NSF's directory is searchable.

3. Trade-show exhibitor lists. In-Cosmetics North America (annual, currently in New York) and Cosmoprof North America (Las Vegas) publish full exhibitor directories. The lists include both formulation-house labs and contract manufacturers. The In-Cosmetics directory is one of the cleanest.

4. The Personal Care Products Council member directory. The PCPC is the U.S. cosmetics industry's main trade association. Members tend to be more compliance-mature than non-members.

5. Competitor product backs. Every U.S. cosmetic product is required to disclose the responsible person on the package. The address on the back of a product is sometimes the brand, sometimes the manufacturer. Worth running through the FDA registry to see which.

None of these is enough alone. Together they yield a candidate pool of 100-300 names that you can filter to a workable shortlist of 8-15.

Two patterns. First, format complexity drives lead time more than MOQ does — sun care and color cosmetics live longer in stability and regulatory checkpoints than basic skincare emulsions. Second, U.S. cosmetics MOQs run tighter than U.S. supplement MOQs at the same dollar volume because container vendors in the cosmetics packaging supply chain run smaller minimums than supplement bottle vendors.

The real cost stack — not just the fill — works the same way as supplements. Container, label, secondary packaging, batch testing, freight, 3PL prep all stack on top of fill cost. Expect 1.6-2.4x the factory's per-unit quote as your real landed cost on first runs.

Six questions, sent in writing before scheduling a discovery call.

1. MoCRA facility registration number and current effective date. Every U.S. cosmetics facility has one. Verifiable against the FDA registry.
2. ISO 22716 certificate (issuing body, certificate number, expiration). If the factory claims GMP compliance without ISO 22716 third-party audit, ask which standard they audit to and who audits them. "Internal QC" is not a standard.
3. Formulation library in your category. "How many stock formulas do you have in [skincare / color / hair / sun care]? What's certified — vegan, cruelty-free, organic, EWG Verified?" Specifics or no relationship.
4. MOQ and lead time at your specific format. Number, not range, on the first-run quote. Ranges signal capacity uncertainty.
5. References — three brands currently in production with shelf presence. Strong factories will name them. Ask for at least one in your category.
6. Adverse event handling. "Under MoCRA, who maintains adverse event records and who files mandatory reports? What does the engagement contract specify?" Tells you whether the factory takes the regulatory layer seriously.

The brief takes a strong factory 30-45 minutes to answer. A response in 5 minutes with marketing copy is the answer. A response that ducks the MoCRA or ISO 22716 questions is also the answer.

The U.S. cosmetics manufacturing industry is not category-uniform. Different clusters specialize.

Skincare emulsions, serums, masks. Southern California is the deepest pool. Hyaluronic acid serums, vitamin C serums, retinol creams, peptide formulations all have multiple capable labs in the Los Angeles / Orange County corridor. Many of the labs run both stock-formula white-label and custom private-label engagements; the distinction matters at the contract stage.

Color cosmetics (lipstick, mascara, foundation, eye shadow). New Jersey heritage industry, with deep tooling and packaging integration. MOQs are higher (often 5,000+ for filled and packed lipstick) because the lines are capital-intensive.

Sun care. Specialized regulatory category — sunscreens are over-the-counter drugs in the U.S., not cosmetics, and follow a different FDA monograph framework. The U.S. SPF manufacturing pool is small and mostly in Florida and California. Lead times longer (12-18 weeks); regulatory review is mandatory.

Hair care. Florida and California share the cluster, with strong textured-hair and curly-hair formulation expertise concentrated in Florida and prestige hair-care emulsions in California.

Clean beauty / EWG Verified / certified organic. Utah and Pacific Northwest cluster has strong audit posture inherited from the supplement industry's compliance culture. Cleaner ingredient decks, more aggressive certification stacks.

Lip balm and stick formats. Indiana, Ohio, and parts of the Midwest have legacy filling capacity for stick formats from the broader personal-care industry. MOQs higher, per-unit cost lower.

Picking the right cluster up front shortens the search. A founder targeting a clean-beauty serum will find better fits in California or Utah than in New Jersey. A founder targeting a color cosmetic will find better fits in New Jersey than in Florida. The clusters are real and they shorten weeks off the discovery cycle.

The default answer for first-time founders launching into the U.S. market at modest volumes is domestic. Here's why.

MoCRA simplifies domestic. A U.S. lab handles your MoCRA facility registration as part of their operational baseline. Importing a finished cosmetic from Korea or Italy means you, the brand, are on the hook for product listing under MoCRA, you may need a U.S. agent for the manufacturer, and the customs broker layer adds 2-4 weeks to lead time and complexity.

EU and UK have parallel but separate regulatory frames. Cosmetic Product Notification Portal (CPNP) for the EU, Submit Cosmetic Product Notifications (SCPN) for the UK. A factory in those regions is filing in those frames. They can produce for U.S. market, but the cross-border regulatory lift is non-trivial.

Korea wins on certain skincare innovations. Snail mucin, centella, fermented actives, sheet-mask formats, and complex multi-step regimes have stronger Korean lab capacity than U.S. lab capacity. If your hero formula is in one of those buckets, a Korean lab plus a U.S. importer of record may be the right call despite the regulatory complexity. Korea's Ministry of Food and Drug Safety publishes the regulatory frame.

Italy and France win on prestige skincare. Heritage formulation IP in luxury skincare. MOQs and price points are usually high; relevant for brands building in the $50+ retail space.

For most U.S. private-label launches in the $24-65 retail price range with 500-5,000 unit first runs, a U.S. lab is faster, simpler, and competitive on cost. Go overseas when category strength, certification, or formula complexity forces it.

Three steps.

One: write the brief. Format, fill volume, indicative retail price, certification asks (vegan, cruelty-free, EWG, USDA Organic), target launch window. Without it the vetting questions don't have a frame.

Two: build a 12-15 candidate shortlist using the five sources above. Filter against the cluster that matches your category. Cross-reference each candidate against the FDA MoCRA registry and the issuing body's ISO 22716 directory.

Three: send the six-question vetting brief. The factories that respond fully inside 3 business days are your real shortlist. Schedule discovery calls with the top 3-5.

If you want to skip the discovery work, brief us. We've sourced both private-label and contract-manufactured runs across cosmetics and skincare, and we'll come back inside 36 hours with three matched U.S. factories — MOQ, lead time, and indicative cost on each.